Abstract
To evaluate whether a simple pharmacist protocol, consisting of patient screening and cardiovascular risk stratification, identification and reminders about uncontrolled risk factors, and drug adherence support, can significantly reduce cardiovascular risk. Prospective, randomized, controlled pilot study. Large primary care medical clinic in Saskatoon, Saskatchewan, Canada. One hundred seventy-six adult patients (mean age 60 yrs) who exhibited a 10-year Framingham risk score of 15% or greater, or a coronary artery disease risk equivalent (coronary artery disease, peripheral artery disease, cerebrovascular disease, or diabetes mellitus). Eligible patients initially met with the pharmacist to receive general counselling about cardiovascular disease and were then randomly assigned to receive ongoing follow-up by the pharmacist (follow-up group [88 patients]) or to return to usual care (single-contact group [88 patients]) for a minimum of 6 months. The primary end point was mean reduction in the 10-year Framingham risk score. Secondary end points included individual modifiable risk factors (systolic and diastolic blood pressures; total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol [HDL], and...Continue Reading
References
Sep 29, 1999·Circulation·S M GrundyV Fuster
Nov 18, 2000·Pharmacotherapy·M BozovichJ Edmunds
May 22, 2002·Archives of Internal Medicine·Ross T TsuyukiJeff G Taylor
Jun 18, 2002·Pharmacotherapy·Jean GeberLisa Korman
Jul 23, 2002·JAMA : the Journal of the American Medical Association·Joshua S BennerJerry Avorn
Aug 16, 2002·Heart·L WeiT M MacDonald
Dec 11, 2002·Current Controlled Trials in Cardiovascular Medicine·Scott A LearJiri J Frohlich
Jan 31, 2003·The New England Journal of Medicine·Peter GaedeOluf Pedersen
Jan 31, 2003·The Journal of Clinical Hypertension·Barry L CarterWilliam J Elliott
May 16, 2003·JAMA : the Journal of the American Medical Association·Aram V ChobanianUNKNOWN National High Blood Pressure Education Program Coordinating Committee
Jul 14, 2004·Circulation·Scott M GrundyUNKNOWN American Heart Association
Jun 7, 2006·The Canadian Journal of Cardiology·B R HemmelgarnUNKNOWN Canadian Hypertension Education Program
Jun 7, 2006·The Canadian Journal of Cardiology·N A KhanUNKNOWN Canadian Hypertension Education Program
Jul 29, 2006·Diabetes Care·David M NathanBernard Zinman
Sep 15, 2006·The Canadian Journal of Cardiology·Ruth McPherson Canadian Cardiovascular Society
Apr 11, 2008·The Journal of Clinical Hypertension·Barry L CarterArthur J Hartz
Citations
Apr 13, 2013·High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension·Georgia PallikaronaYannis Tountas
Oct 29, 2013·Research in Social & Administrative Pharmacy : RSAP·Edwin C K TanJohnson George
Jul 24, 2014·International Journal of Clinical Pharmacy·Lucas Miyake OkumuraCassyano Januário Correr
Jul 27, 2010·Pharmacotherapy·Barry L Carter
May 31, 2014·Pharmacotherapy·Debbie A McCueAmy M Pick
Jun 17, 2015·Journal of the American Society of Hypertension : JASH·Tyler H GumsBarry L Carter
Jul 15, 2016·Preventive Medicine·Joshua A RashTavis S Campbell
Sep 30, 2016·Drugs·Magnus Jörntén-KarlssonMatti Ahlqvist
Oct 5, 2013·Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC·Erin M YakiwchukDavid F Blackburn
May 3, 2014·The Cochrane Database of Systematic Reviews·Kate E LagerAndrew D Wilson
Nov 21, 2014·The Cochrane Database of Systematic Reviews·Robby NieuwlaatR Brian Haynes
Aug 24, 2018·Journal of Atherosclerosis and Thrombosis·Makoto KinoshitaUNKNOWN Committee for Epidemiology and Clinical Management of Atherosclerosis
Oct 23, 2017·BMJ Quality & Safety·Susan WellsDon Goldmann
Mar 16, 2017·The Cochrane Database of Systematic Reviews·Kunal N KarmaliMark D Huffman
May 10, 2020·The Cochrane Database of Systematic Reviews·Amanda J CrossJohnson George
May 8, 2018·The Cochrane Database of Systematic Reviews·Bernadeta BridgwoodPriya Modi
Jan 17, 2020·Population Health Management·Addie L FortmannAthena Philis-Tsimikas
May 19, 2020·Journal of Clinical Lipidology·Dave L DixonWilliam L Baker
Mar 18, 2021·The International Journal of Pharmacy Practice·Matthew J Miller, Robert T Pammett
Aug 7, 2021·Research in Social & Administrative Pharmacy : RSAP·Natalie M WeirMarion Bennie
Apr 17, 2018·Research in Social & Administrative Pharmacy : RSAP·Sheila Anne Doggrell